PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES
Recalling firm: Beta Labs
Why it was recalled
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
The exact product
PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822
Check the codes
Compare these FDA-provided codes, lot numbers or dates with the product you have.
Match the product, size and code together. A similar name alone does not identify your batch.
Original FDA code information
Lot # 58800512, Exp 05/16
| Type | Code / value | Context |
|---|---|---|
| UPC | 670541599822 | dra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822 |
| lot | 58800512 | Lot # 58800512, Exp 05/16 |
Recall details
- Recall number
- F-2399-2014
- Event ID
- 65585
- FDA status
- Terminated
- Initiated
- Jun 20, 2013
- Reported
- Sep 3, 2014
- Classified
- Aug 27, 2014
- Terminated
- Dec 3, 2014
- Quantity
- 2154 units
- Location
- Memphis, TN, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Press Release
Where it was distributed
nationwide and UK
FDA source record · F-2399-2014
Data updated September 16, 2026. View official FDA data ↗
A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.